Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.690
-0.070 (-1.86%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Revenue
Zentalis Pharmaceuticals had revenue of $40.56M in the twelve months ending June 30, 2024.
Revenue (ttm)
$40.56M
Revenue Growth
n/a
P/S Ratio
6.57
Revenue / Employee
$327,097
Employees
124
Market Cap
262.39M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Viemed Healthcare | 205.70M |
Akebia Therapeutics | 174.50M |
Sutro Biopharma | 169.36M |
Rigel Pharmaceuticals | 130.20M |
Personalis | 80.03M |
Editas Medicine | 67.03M |
AVITA Medical | 54.14M |
Nyxoah | 5.13M |
ZNTL News
- 9 days ago - Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - PRNewsWire
- 10 days ago - FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers - Benzinga
- 10 days ago - Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies - GlobeNewsWire
- 17 days ago - Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024 - GlobeNewsWire
- 23 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL - Business Wire
- 5 weeks ago - Investors In Zentalis Pharmaceuticals Inc Encouraged To Participate In Fraud Investigation With The Schall Law Firm - Accesswire
- 5 weeks ago - Shareholders With Losses In Zentalis Pharmaceuticals Inc Invited To Join Fraud Investigation With Schall Law Firm - Accesswire